SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-149413
Filing Date
2023-05-19
Accepted
2023-05-19 16:39:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFA14A d388197ddefa14a.htm DEFA14A 25763
2 GRAPHIC g388197dsp2a.jpg GRAPHIC 13860
3 GRAPHIC g388197dsp2b.jpg GRAPHIC 4359
4 GRAPHIC g388197dsp2c.jpg GRAPHIC 13211
5 GRAPHIC g388197dsp2d.jpg GRAPHIC 2406
6 GRAPHIC g388197dsp2e.jpg GRAPHIC 11220
7 GRAPHIC g388197dsp2f.jpg GRAPHIC 1809
8 GRAPHIC g388197dsp2g.jpg GRAPHIC 1485
9 GRAPHIC g388197dsp2h.jpg GRAPHIC 850
  Complete submission text file 0001193125-23-149413.txt   95606
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41583 | Film No.: 23940966
SIC: 2834 Pharmaceutical Preparations